Central Arterial Hemodynamic Effects of Dark Chocolate Ingestion in Young Healthy People: A Randomized and Controlled Trial

Table 2

Variation of the clinical parameters per group and per assessment moment.

	Control group (𝑛=30)			Intervention group (𝑛=30)
	Baseline	30 days	𝑃	Baseline	30 days	𝑃
BMI, Kg/m^2	23.55±3.51	23.63±3.49	0.22	22.18±3.87	22.15±3.92	0.61
HR, bpm	75.00±15.19	74.15±19.07	0.90	72.20±10.30	72.20±9.78	1.00
bSBP, mmHg	120.00±12.56	121.57±12.00	0.62	120.33±7.67	116.67±7.48	0.10
bDBP, mmHg	68.21±7.50	68.07±6.84	0.92	67.67±6.78	66.00±6.60	0.42
cSBP, mmHg	109.92±13.66	111.46±12.25	0.90	110.6±8.49	109.00±8.37	0.53
cPP, mmHg	43.00±10.95	43.00±9.99	1.00	44.92±10.52	42.33±10.18	0.19
AiX, %	−17.54±13.78	−16.15±15.72	0.68	−15.88±10.75	−22.57±11.16	0.07
ASI,	0.15±0.02	0.14±0.07	0.10	0.16±0.01	0.13±0.01	0.00
PWV, m/s	6.28±0.95	6.30±1.13	0.52	6.13±0.41	5.83±0.53	0.02
FMD, %	12.85±4.51	13.23±5.76%	0.70	13.91±4.71%	23.22±7.64%	0.00

AiX: augmentation index; ASI: distensibility index; BMI: body mass index; bDBP: brachial diastolic blood pressure; bSBP: brachial systolic blood pressure; cPP: central pulse pressure; cSBP: central systolic blood pressure; HR: heart rate; PWV: pulse wave velocity; FMD: flow-mediated dilation.